Literature DB >> 12416577

Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.

Yoshihiro Imamura1, Takaya Fukuyama.   

Abstract

OBJECTIVE: To assess the prognostic value of I-123 metaiodobenzylguanidine (MIBG) scintigraphy findings, and establish the most appropriate method for calculating myocardial MIBG activity in patients with left ventricular dysfunction due to cardiomyopathy (CM).
METHODS: Predictors of cardiac death related to progressive heart failure (HF) were examined in 150 patients with CM (80 patients with idiopathic CM and 70 patients with ischemic CM). All patients underwent MIBG scintigraphy at rest and other hemodynamic studies when their clinical status was stable. MIBG scintigrams were obtained 15 minutes and 4 hours after the injection of the isotope. The parameters for quantification of myocardial MIBG activity were heart/mediastinal activity ratio (H/M) and myocardial washout rate (WR). The WR was calculated with and without background (BG) correction.
RESULTS: The WR showed better correlation with plasma norepinephrine and left ventricular ejection fraction after BG correction. During a mean follow-up period of 33 +/- 9 (7 to 54) months, 12 patients died due to HF; 7 patients due to progressive HF and 5 patients due to sudden cardiac death. Cox regression analysis indicated, the H/M and the WR with and withoutBG correction, were significant predictors of cardiac death (Wald chi-squared value: H/M [ 15 min] = 9.7, H/M [4 hr] = 19.5, WR with BG correction = 29.9, WR without BG correction = 12.6). WR prognostic value was better after BG correction, and a high WR with BG correction was the only independent predictor of cardiac death (relative risk [RR] = 1.174, p < 0.0001).
CONCLUSIONS: Accelerated WR is a powerful predictor of the patient's prognosis and BG correction is essential for calculating WR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416577     DOI: 10.1007/bf02990076

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

1.  Norepinephrine spillover during exercise as a novel parameter to evaluate the severity of heart failure.

Authors:  Miyuki Ando; Takeshi Yamamoto; Akihiro Hino; Takashi Sato; Yasuma Nakamura; Masunori Matsuzaki
Journal:  J Nucl Cardiol       Date:  2010-05-26       Impact factor: 5.952

Review 2.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

3.  Perindopril vs Enalapril in Patients with Systolic Heart Failure: Systematic Review and Metaanalysis.

Authors:  James J DiNicolantonio; Tian Hu; Carl J Lavie; James H O'Keefe; Sripal Bangalore
Journal:  Ochsner J       Date:  2014

4.  Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.

Authors:  Takuji Toyama; Hiroshi Hoshizaki; Shu Kasama; Yusuke Miyaishi; Hakuken Kan; Eiji Yamashita; Ren Kawaguti; Hitoshi Adachi; Shigeru Ohsima
Journal:  J Nucl Cardiol       Date:  2016-07-07       Impact factor: 5.952

Review 5.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 10.057

6.  Uptake Index of 123I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease.

Authors:  Yoshito Kamiya; Satoru Ota; Shintaro Okumiya; Kosuke Yamashita; Akihiro Takaki; Shigeki Ito
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

7.  Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.

Authors:  Hein J Verberne; G Aernout Somsen; Pavol Povinec; Berthe L F van Eck-Smit; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

8.  Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure.

Authors:  Giuseppe Rengo; Gennaro Pagano; Pasquale Perrone Filardi; Grazia Daniela Femminella; Valentina Parisi; Alessandro Cannavo; Daniela Liccardo; Klara Komici; Giuseppina Gambino; Maria Loreta D'Amico; Claudio de Lucia; Stefania Paolillo; Bruno Trimarco; Dino Franco Vitale; Nicola Ferrara; Walter J Koch; Dario Leosco
Journal:  Circ Res       Date:  2016-02-16       Impact factor: 17.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.